Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks

Brief Summary

The objective of this study is to evaluate the effectiveness of ketamine (infusion of 0.5mg/kg) and venlafaxine compared to the use of venlafaxine alone in the treatment of major depression (MADRS score ≥ 20 ) to six weeks of treatment.

Intervention / Treatment

  • Drug: ketamine venlafaxine
  • Drug: Venlafaxine

Condition or Disease

  • Major Depressive Disorder

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 18 Years and older   (Adult, Older Adult)
Enrollment: 25 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Mar 12, 2020
Primary Completion: Jan 17, 2020
Completion Date: Jan 17, 2020
Study First Posted: Mar 19, 2012
Results First Posted: Aug 31, 2020
Last Updated: Feb 24, 2017

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 18

More Details

NCT Number: NCT01557712
Acronym: KETADEP
Other IDs: 1129
Study URL: https://ClinicalTrials.gov/show/NCT01557712
Last updated: Mar 18, 2021